Lubrizol LifeSciences Announces New Compounding Capabilities
(Thomson Reuters ONE) -
News Release
Lubrizol LifeSciences Announces New Compounding Capabilities
CLEVELAND, February 7, 2017 -The Lubrizol Corporation's LifeSciences (LLS)
business is pleased to announce the addition of compounding capabilities for
its Pellethane(®) and Isoplast(®) products for medical device customers. This
new offering enables LLS to provide color matching, radiopacity and custom
compound development services and complements LifeSciences' existing polymer
portfolio, formulation and manufacturing capabilities to enable success for
medical device customers.
As part of this new service, LLS provides custom color matching for brand
recognition, safe identification and aesthetics in medical device applications.
Since pigment requirements are ever changing, LifeSciences pays close attention
to ensure that colorants meet applicable regulatory requirements.
Along with color matching, LLS also offers radiopaque materials for X-ray
identification and proper device positioning; critical for patient safety and
comfort. Pellethane and Isoplast compounds with barium sulfate and tungsten are
now both available from LLS.
Pellethane thermoplastic polyurethane is available as aromatic polyethers or
polyesters and are known for their flexibility and wide range of hardness.
Pellethane TPUs are excellent for a variety of medical applications including
tubing, catheters and other short-term uses.
Isoplast engineered thermoplastic polyurethanes are designed for rigid polymer
requirements due to their high tensile strength and impact resistance. Isoplast
medical polymers may be used to replace polycarbonate where stress cracking is
an issue or coloring is difficult. Isoplast is ideal for applications needing an
impact resistance-based polymer.
This new capability is made possible through a partnership with trusted custom
medical plastics compounder, Compounding Solutions. Compounding Solutions is
committed to manufacturing specialty plastics compounds and concentrates of the
highest quality in order to satisfy requirements of the medical device
industry.
- more -
About Lubrizol LifeSciences
Lubrizol LifeSciences is a healthcare solution partner that provides customer
support from idea to execution by supplying customizable polymers and
excipients, complex drug formulation development and best-in-class contract
manufacturing services for medical device and pharmaceutical manufacturers. The
combination of our polymer expertise, drug formulation development and quality
contract manufacturing allows LifeSciences to offer our customers end-to-end
solutions for success in the medical device and drug delivery market.
About Compounding Solutions
Compounding Solutions was started in 1999 with the purpose of becoming a leading
compounder for the medical device industry. At the beginning, the company
operated with two compounding lines and has experienced continued growth through
the years. Currently, the company operates 13 compounding lines and has grown to
over 70 employees.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven
global company that combines complex, specialty chemicals to optimize the
quality, performance and value of customers' products while reducing their
environmental impact. It produces and supplies technologies to customers in the
global transportation, industrial and consumer markets. These technologies
include lubricant additives for engine oils, driveline and other transportation-
related fluids, industrial lubricants, as well as additives for gasoline and
diesel fuel. In addition, Lubrizol makes ingredients and additives for home care
and personal care products and specialty materials encompassing polymer and
coatings technologies, along with polymer-based pharmaceutical and medical
device solutions. Our products for the oilfield market include technologies for
exploration, production and transportation.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing
facilities in 17 countries, as well as sales and technical offices around the
world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide.
Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.
Pellethane(®) and Isoplast(®) are registered trademarks of the Lubrizol
Corporation.
Media Contact
Ben Patti
Benjamin.patti(at)lubrizol.com
(216) 447-5827
www.lubrizol.com/LifeSciences
###
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 07.02.2017 - 17:00 Uhr
Sprache: Deutsch
News-ID 522612
Anzahl Zeichen: 5513
contact information:
Town:
Wickliffe, Ohio
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 134 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Lubrizol LifeSciences Announces New Compounding Capabilities"
steht unter der journalistisch-redaktionellen Verantwortung von
Lubrizol (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
